Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model. - Wikidata - awgldk - TriplyDB

Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model.

Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model.

http://www.wikidata.org/entity/Q41255321

about

Adult stem cells as a tool for kidney regeneration Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients Management of fibrosis: the mesenchymal stromal cells breakthrough Regenerative medicine for the kidney: renotropic factors, renal stem/progenitor cells, and stem cell therapy Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis Stem cells: potential and challenges for kidney repair Progenitor-like cells derived from mouse kidney protect against renal fibrosis in a remnant kidney model via decreased endothelial mesenchymal transition.Mesenchymal stem cell-based therapy in kidney transplantation Mesenchymal stem cell treatment for chronic renal failure.Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation.Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells.Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients Immunomodulatory effect of mesenchymal stem cells on B cells.Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study.Decellularized scaffold of cryopreserved rat kidney retains its recellularization potential.Challenges and opportunities for stem cell therapy in patients with chronic kidney disease Skeletal Muscle-Derived Stem/Progenitor Cells: A Potential Strategy for the Treatment of Acute Kidney Injury.Mesenchymal stromal cells in transplantation rejection and tolerance.Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study.De novo kidney regeneration with stem cells.Concise review: stem/progenitor cells for renal tissue repair: current knowledge and perspectives.Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion.Tolerance in organ transplantation: from conventional immunosuppression to extracellular vesicles.Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive In vitro and in a Humanized Allograft Rejection Model.Cell-based therapy for kidney disease.Mesenchymal stromal cells in renal transplantation: opportunities and challenges.Modulation of Immune Responses by Mesenchymal Stromal Cells.NK Cells and MSCs: Possible Implications for MSC Therapy in Renal Transplantation.Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial.Beneficial Effects of Systemically Administered Human Muse Cells in Adriamycin Nephropathy.Biodistribution and Immunogenicity of Allogeneic Mesenchymal Stem Cells in a Rat Model of Intraarticular Chondrocyte Xenotransplantation.The Timing of Immunomodulation Induced by Mesenchymal Stromal Cells Determines the Outcome of the Graft in Experimental Renal Allotransplantation.Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review.The effect of rabbit antithymocyte globulin on human mesenchymal stem cells.Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial.Stromal cells in tissue homeostasis: balancing regeneration and fibrosis.Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models.Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy.Autologous Mesenchymal Stromal Cells Prevent Transfusion-elicited Sensitization and Upregulate Transitional and Regulatory B Cells

P2860

Q26770750-768DA3A1-33EF-4825-AE4F-B97B6C2A8BFC Q26799916-7428538B-AD3E-4FB5-8618-ED4654F7610B Q26827231-B5B22CC9-EFAD-4819-8C1C-ADFD106ECE8D Q26865171-68E255BD-45A2-4CC0-8EBB-EBD41B1D090B Q26866578-A5EDCE71-A39A-44B0-98BE-474736544313 Q27006024-7C5E4153-040C-44EF-9ACE-11F8AF91D060 Q27322429-16D5D3D1-D710-4FBA-8BFF-FD82740CFFCB Q28069543-8F71E556-E363-494E-BC27-CA9C8EAAADCF Q33900483-DF88FBAF-286D-4A79-8ADE-871DC2FA59DE Q34259085-C4F0CF61-CB66-468D-A8F2-5F051BC37BE2 Q34289498-8CA205F9-F430-46E4-9D92-499C9E49A9A3 Q34751391-97378B91-D99E-4D8D-872F-308E545856F3 Q34753440-689B80A9-341D-4A53-A671-334FCEB2CFED Q36105639-0620411C-8675-4002-9C1A-1501D3059C83 Q36246918-572767A3-8388-4603-8925-449084288950 Q36299555-FA42489D-F65D-4D6D-939D-D6999C2A0AD4 Q36711673-7FA54169-DFDA-400E-8C06-4C4C486A1151 Q36742046-0F700ECC-2935-4DBC-9475-1E627601CC4B Q36786630-80D14465-20BF-4844-AB14-158F86A22EB5 Q36861751-5C73E13B-E10B-4CAA-88A6-4B5CD580757C Q38068400-F8E36976-0F9C-496F-B1B3-537DE1DE95D4 Q38156153-0FA13688-A772-4110-B391-E59F23E206A0 Q38187110-478351C4-B94A-44AA-9F75-FACC9204DC4F Q38256369-ADEC5845-6866-479A-BBF1-05A5ACC6234B Q38439453-09EDA2C8-D07E-4564-82BC-77FD2AFF0FF4 Q38528934-28D1FA9B-94A4-495C-8859-1E74F2BB5891 Q38725481-C471A2D2-624F-491E-B778-891ADD6C1CE2 Q38945318-0A1F6E2C-52B8-43F4-BC74-0B915651A35E Q40133843-1606F376-F40D-40CF-98EA-E3B0F99EF52F Q45874551-E1B734C0-67B8-445C-9167-8879766368D5 Q46348462-B7C111BA-B715-478C-A9BF-A573CA4B33AC Q47123674-D28695DD-387F-4204-B4DC-62FD497C41F9 Q47345486-0E5F9FF8-A380-48CC-96C1-AA9FCB303546 Q50042214-649AFF32-3734-44C2-9B78-F2C59F30B613 Q50986513-5DE5874F-7F9D-4986-BDAD-8492786121E4 Q52668825-4EFB69BF-EF13-4DEB-9ED2-6C9AD4088091 Q53094692-AF23C573-E910-407F-8198-8B68B46B179A Q55401793-FD5C4F55-4FC2-401F-803D-2459EE6C73B1 Q55450034-BF0345AA-C749-4748-803B-9956984E990C Q58700304-8E1FB0DE-D54E-4936-80AA-90DEC83FB1AE

P2860

Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model.

http://www.wikidata.org/entity/Q41255321

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Mesenchymal stem cell therapy ...... a rat kidney allograft model.

@en

type

label

Mesenchymal stem cell therapy ...... a rat kidney allograft model.

@en

prefLabel

Mesenchymal stem cell therapy ...... a rat kidney allograft model.

@en

P1433

Q41255321-B1200D98-D521-4C7B-BA0A-6E0FE605522D

P1476

Q41255321-444E748F-A985-45D1-854B-4ED78FF4B37F

P2093

Q41255321-041367B4-1693-49B6-8CB3-AE7B28973378

Q41255321-0820E2FC-CCCD-4154-B9D9-E82919DA8432

Q41255321-2173C7F6-5445-414C-9A1D-01235D6AEAAB

Q41255321-2907FCE8-6C38-4991-9AB9-F44040CC1E4C

Q41255321-3E6F43BB-5776-4F58-8383-33AC18183CB7

Q41255321-41D2AF37-1F1D-46AF-814F-40918AF3967B

Q41255321-7545853D-85AE-4380-8324-FE2715416220

Q41255321-8F827FCE-A278-4E7B-9153-FFBFD1CF9C79

Q41255321-C7F2330A-2C72-49BA-AC9B-D05217C62EE8

Q41255321-D9A55744-5F5B-4EF6-B492-D41913740DF2

P2860

Q41255321-00D9F5EF-C300-4FA6-83BF-0CBBAC81EDA7

Q41255321-03A4D8AC-BCD9-4C94-96C3-8BEA62562977

Q41255321-0606BD51-FC0C-4103-8AEE-308A662E3C28

Q41255321-143C1742-7337-4E50-9E43-390DDD7AC286

Q41255321-16D2E841-B793-45CC-B136-DEC3CE4A69A8

Q41255321-197B2B45-5541-4199-BAEE-F875A447DAB7

Q41255321-19F671CA-21F0-4D7B-99B9-746483156A80

Q41255321-28D095DE-74F5-48CE-BD3E-390C52E891F8

Q41255321-2A200652-0760-4DEA-8134-DA88688759D1

Q41255321-3F96F044-7E23-4097-8F54-95999D6122E5

P304

Q41255321-3AAD3B87-E901-4CB0-B835-FD219C448D18

P31

Q41255321-A006257B-29A0-43F2-8723-091CE88D9BA3

P356

Q41255321-6A39773D-A39B-4817-B31E-8515FF3A27B5

P433

Q41255321-2527E6C1-9E50-4549-B93A-B17D06EC9084

P478

Q41255321-E65A0650-63F9-4A7E-80B8-5FD7E79DA3E4

P577

Q41255321-B615702C-BC3F-4DF6-B145-BFC70DBB1A9D

P5875

Q41255321-ADFE64ED-0509-46EF-8FC1-7D15038C497E

P698

Q41255321-065C52AA-83C1-46FD-A59C-B834E210B949

P932

Q41255321-0965C85E-7CA4-4E1F-8210-C9290A4AF8DD

P356

P1433

Stem Cells and Development

P1476

Mesenchymal stem cell therapy ...... a rat kidney allograft model.

@en

P2093

Elia Ripoll

http://www.w3.org/2001/XMLSchema#string

Esther Herrero

http://www.w3.org/2001/XMLSchema#string

Ignacio Anegon

http://www.w3.org/2001/XMLSchema#string

Immaculada Herrero-Fresneda

http://www.w3.org/2001/XMLSchema#string

Joan Torras

http://www.w3.org/2001/XMLSchema#string

Josep M Cruzado

http://www.w3.org/2001/XMLSchema#string

Josep M Grinyó

http://www.w3.org/2001/XMLSchema#string

Marcella Franquesa

http://www.w3.org/2001/XMLSchema#string

Maria Flaquer

http://www.w3.org/2001/XMLSchema#string

Montse Gomà

http://www.w3.org/2001/XMLSchema#string

P2860

Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration

Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase

New lines of GFP transgenic rats relevant for regenerative medicine and gene therapy.

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

Suramin inhibits renal fibrosis in chronic kidney disease.

Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation.

Marrow Stromal Cell Infusion Rescues Hematopoiesis in Lethally Irradiated Mice despite Rapid Clearance after Infusion.

Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation.

Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

P304

3125-3135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/SCD.2012.0096

http://www.w3.org/2001/XMLSchema#string

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223975753

http://www.w3.org/2001/XMLSchema#string

P698

22494435

http://www.w3.org/2001/XMLSchema#string

P932

3495114

http://www.w3.org/2001/XMLSchema#string